LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

Home・Aandelen Lijst・Alcon Inc

Alcon Inc

Gesloten

SectorGezondheidszorg

66.57 3.5

Buy Sell

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

64.21

Max

66.58

Belangrijke statistieken
By Trading Economics
Inkomsten	-32M 185M
Verkoop	-65M 2.7B
K/W Sectorgemiddelde	39.341 49.888
EPS	0.85
Dividendrendement	0.55
Winstmarge	6.984
Werknemers	25,000
EBITDA	168M 689M

Aanbevelingen
By TipRanks
Aanbevelingen	Buy
12 Maanden Prognose	+34.72% upside

Dividenden
By Dow Jones
Dividendrendement Sectorgemiddelde	0.55% 2.38%
Volgende Winsten	10 aug 2026

Marktinformatie
By TradingEconomics
Marktkapitalisatie	-4.7B 32B
Vorige openingsprijs	63.07
Vorige sluitingsprijs	66.57

Nieuwssentiment

By Acuity

26%

74%

59 / 344 Rangschikking in Healthcare

Alcon Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

17 mrt 2026, 14:42 UTC

Belangrijke Marktbewegers

Acquisities, Fusies, Overnames

Lensar Share Slide on Terminated Merger Deal With Alcon

16 mrt 2026, 21:37 UTC

Acquisities, Fusies, Overnames

Lensar and Alcon Agree to Terminate Merger

6 jan 2026, 15:11 UTC

Acquisities, Fusies, Overnames

Staar Surgical Shareholders Reject $1.6 Billion Acquisition by Alcon in Activist Win

9 dec 2025, 18:51 UTC

Acquisities, Fusies, Overnames

Broadwood Partners Still Opposes Alcon's Higher Bid for Staar Surgical

9 dec 2025, 15:54 UTC

Belangrijke Marktbewegers

Acquisities, Fusies, Overnames

Staar Surgical Shares Surge as Alcon Boosts its Buyout Price

9 dec 2025, 14:32 UTC

Acquisities, Fusies, Overnames

Alcon Upgrades Offer Price for Staar Surgical

5 mei 2026, 21:25 UTC

Winsten

Alcon Inc. 1Q EPS 39c >ALC.EB

5 mei 2026, 21:25 UTC

Winsten

Alcon Inc. 1Q Rev $2.71B >ALC.EB

16 mrt 2026, 20:59 UTC

Acquisities, Fusies, Overnames

Alcon: Transaction Unattractive to Pursue Further in Light of FTC's Opposition

16 mrt 2026, 20:59 UTC

Acquisities, Fusies, Overnames

Alcon: Delay and Associated Costs of Extended Regulatory Review Has Rendered Deal Unattractive to Pursue Further

16 mrt 2026, 20:59 UTC

Acquisities, Fusies, Overnames

Alcon Entered Agreement With LENSAR to Terminate Merger Agreement

16 mrt 2026, 20:57 UTC

Acquisities, Fusies, Overnames

Alcon and LENSAR, Inc. Agree to Terminate Merger Agreement

25 feb 2026, 22:29 UTC

Acquisities, Fusies, Overnames

Lensar Expects to Close Transaction in 1H of 2026 >LNSR

25 feb 2026, 22:29 UTC

Acquisities, Fusies, Overnames

Lensar, Alcon Continue to Cooperate With FTC in Connection With Request for Additional Info >LNSR

25 feb 2026, 22:28 UTC

Acquisities, Fusies, Overnames

LENSAR Provides Update on Pending Acquisition by Alcon

24 feb 2026, 21:41 UTC

Winsten

Alcon 4Q Rev $2.72B >ALC.EB

7 jan 2026, 01:00 UTC

Acquisities, Fusies, Overnames

Alcon Terminates Agreement To Acquire STAAR Surgical >ALC

6 jan 2026, 22:03 UTC

Acquisities, Fusies, Overnames

Staar Surgical: Merger Proposal Received 14.9M Votes For and 27.3M Against

6 jan 2026, 22:03 UTC

Acquisities, Fusies, Overnames

Staar Surgical, Which Earlier Reported Stockholder Rejection of Sale to Alcon, Reports Vote Totals

6 jan 2026, 15:21 UTC

Marktinformatie

Acquisities, Fusies, Overnames

Staar May See Management Turnover After Alcon Bid Is Rejected -- Market Talk

6 jan 2026, 14:56 UTC

Acquisities, Fusies, Overnames

Staar Surgical Shareholders Reject $1.6B Acquisition by Alcon in Activist Win

6 jan 2026, 14:14 UTC

Acquisities, Fusies, Overnames

Staar Surgical: Will Remain a Standalone, Publicly Traded Co and Continue to Trade on Nasdaq >STAA

6 jan 2026, 14:14 UTC

Acquisities, Fusies, Overnames

Staar Surgical: No Termination Fee Will Be Payable by Either Party >STAA

6 jan 2026, 14:14 UTC

Acquisities, Fusies, Overnames

Staar Surgical: Intend to Terminate Merger Agreement With Alcon >STAA

6 jan 2026, 14:13 UTC

Acquisities, Fusies, Overnames

Staar Surgical: Did Not Receive Necessary Stockholder Votes to Approve Merger Agreement With Alcon >STAA

9 dec 2025, 14:17 UTC

Acquisities, Fusies, Overnames

Alcon Ups Offer Price for Staar Surgical

9 dec 2025, 13:34 UTC

Acquisities, Fusies, Overnames

Alcon: Transaction Now Represents a Total Equity Value of $1.6B >ALC.EB

9 dec 2025, 13:33 UTC

Acquisities, Fusies, Overnames

Alcon: Purchase Price Increase Represents an Additional $150M >ALC.EB

9 dec 2025, 13:33 UTC

Acquisities, Fusies, Overnames

Alcon: Under the Terms of the Amended Agreement, Alcon Will Purchase All Outstanding Shrs of STAAR for $30.75 Per Shr in Cash >ALC.EB

9 dec 2025, 13:33 UTC

Acquisities, Fusies, Overnames

Alcon To Finance Transaction Through Issuance of Short- and Long-Term Credit Facilities >ALC

Peer Vergelijking

Prijswijziging

Alcon Inc Prognose

Koersdoel

By TipRanks

34.72% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 86.52 USD 34.72%

Hoogste 108.762 USD

Laagste 63.234 USD

Gebaseerd op 12 Wall Street-analisten die 12-maands prijsdoelen bieden voor Alcon Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

12 ratings

Buy

Hold

Sell

Gebaseerd op 12 analisten die aandelenratings hebben gegeven aan Alcon Inc - Dist in de afgelopen 3 maanden.

Sentiment

By Acuity

59 / 344 Rangschikking in Gezondheidszorg

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

Over Alcon Inc

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products for eye care professionals and their patients worldwide. The company's Surgical segment offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, ARGOS biometer, LuxOR surgical ophthalmic microscope, SMARTCATARACT health platform, NGENUITY 3D visualization system, Verion reference unit and Verion digital marker, and ORA system for intra-operative measurements; custom pak surgical procedure packs; vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, and grieshaber and MIVS instruments, as well as scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; refractive surgery products, including WaveLight lasers and Contoura Vision used for LASIK treatment; EX-PRESS glaucoma filtration device; and implantable products, including AcrySof IQ products, such as monofocal IOLs and advanced technology IOLs for the correction of presbyopia and astigmatism at the time of cataract surgery. Its Vision Care segment provides daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, glaucoma, contact lens care, and ocular allergies; and ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.